Cancer immunotherapy: Macrophages steal the show
Nature Reviews Drug Discovery 16, 455 (2017).
doi:10.1038/nrd.2017.126
Author: M. Teresa Villanueva
The past decade has seen remarkable advances in tumour immunology due to extensive research on inhibition of programmed cell death protein 1 (PD1) — which is expressed on T cells — and its ligand PDL1, which is expressed on tumour cells. However, little is known
Source: Nature Reviews Drug Discovery - Category: Drugs & Pharmacology Authors: M. Teresa Villanueva Tags: Research Highlight Source Type: research